Evox Therapeutics completes GBP69.2m Series C financing
Evox Therapeutics (Evox), an exosome therapeutics company, has raised GBP69.2 million (USD95.4 million) in a Series C financing round. The financing was significantly oversubscribed with high demand from both existing and new investors. The Series C financing was led by Redmile Group who were joined by new investors OrbiMed and
